2023-06-28 03:14:41 ET
-
Axsome Therapeutics ( NASDAQ: AXSM ) said Tuesday it plans to conduct a public offering of its common stock.
-
The underwriters are expected to have a 30-day option to purchase up to an additional 15% of the shares of common stock.
-
All of the shares in the offering are to be sold by Axsome.
-
Net proceeds from the offering will be used to advance its late-stage pipeline and for other general corporate purposes.
-
Details on pricing and the number of shares to be offered were not disclosed.
-
More on Axsome
- Axsome sees peak US sales of marketed drugs of up to $3.5B
-
Axsome Therapeutics: Reviewing Q1 2023 Financials And Pipeline Updates
-
Axsome Therapeutics: A Prescription For Success In The CNS Space
For further details see:
Axsome Therapeutics to raise capital via stock offering